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 Porphyromonas gingivalis (P. gingivalis) is a gram-negative, anaerobic bacterium 
recognized as a major player in progression of periodontal disease. P. gingivalis survives 
in the oral cavity while being exposed to dynamic environmental conditions such as pH, 
temperature, nutrient availability and host immune responses such as oxygen tension and 
nitrosative stress. Survival and pathogenesis of P. gingivalis in the oral cavity require 
mechanisms to regulate gene expression in response to the extracellular signals. Little is 
known about the regulatory mechanisms of P. gingivalis in the oral cavity, so it is 
important to investigate and characterize these regulatory mechanisms. 
 Adaptation to environmental cues using riboregulation is a significant mechanism 
   xiv 
for post-transcriptional regulation in bacteria. Using bioinformatics, we have identified a 
putative RNA-binding protein in P. gingivalis: RBP. Bioinformatic studies have led to the 
selection of HUβ and HUα nucleoid associated proteins as controls for RNA binding.  I 
hypothesize that the candidate proteins RBP, HUβ and HUα bind RNA in P. gingivalis. 
The first aim is to show that RBP, HUβ and HUα bind RNA. Using electrophoretic 
mobility shift assays with IRE RNA and synthesized RNA motifs, I have confirmed that 
the proteins do bind RNA. The second aim is to isolate and sequence the P. gingivalis 
RNA that bind to RBP, HUβ and HUα. I have isolated the RNAs that bound the proteins 
and determined identity of the RNA using high throughput sequencing. Finally, I have 
identified an antibody that specifically binds RBP to use for in vivo immunoprecipitation 
of RNA-protein complexes from P. gingivalis. In conclusion RBP, HUβ and HUα are 
novel RNA binding proteins in P. gingivalis, and further investigation of these proteins is 
necessary to understand the mechanisms of gene regulation in P. gingivalis. 
 
 
 
 
 
 
 
 
  
CHAPTER 1: INTRODUCTION 
 
1.1. BACKGROUND AND SIGNIFICANCE 
1.2. Periodontal Disease 
The oral cavity has a unique bacterial flora that is highly diverse (Aas et al., 2005). 
The normal flora of the healthy oral cavity consists primarily of gram-positive organisms 
in the plaque biofilm (Ezzo et al., 2003). The shift to a more gram-negative biofilm results 
in the development of periodontal disease (Ezzo et al., 2003).  The disruption in the 
commensalism by proteolytic bacteria leads to inflammation of the periodontal epithelium, 
pathogen invasion, and the development of periodontal disease (Darveau, Tanner et al., 
1997). The most prevalent organisms associated with periodontal diseases are 
Porphyromonas gingivalis, Prevotella intermedia, Tannerella forsythia, Campylobacter 
rectus, and Treponema denticola (Ezzo et al., 2003). 
 Periodontitis is a common oral disease that affects at least 35% of U.S. adults 
between the age of 30 to 90 (Albandar et al., 1999) and about 300 million people globally 
(Wayakanon et al., 2013). The disease ranges in severity from gum inflammation to a 
more serious condition resulting in damage to the soft tissue and alveolar bone that 
support teeth. 
 Gingivitis is the initial stage of the disease characterized by inflammation. During 
this stage of gum disease, there is no loss of bone or tissue that holds teeth in place.  
Gingivitis can usually be reversed with daily brushing and flossing, and regular cleaning 
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by a dentist or dental hygienists. If left untreated, gingivitis can develop into periodontitis. 
Periodontitis is characterized by severe inflammation of the periodontium caused by 
bacterial biofilm on the tooth surface called plaque (Kinane et al., 2008). In severe 
periodontitis, gums pull away from the teeth and form pockets that become infected 
(Savage et al., 2009). The bacteria of the plaque adhere to the tooth and bone and release 
endotoxins and degradative enzymes that trigger a host immune response. The endotoxins 
and degradative enzymes in conjunction with our bodies’ inflammatory immune response 
break down the alveolar bone and connective tissue that surround and support the teeth, 
often resulting in tooth loss (Weinmann et al., 2011).   
 Periodontitis is also associated with systemic conditions—increased risk of 
coronary heart diseases (Nibali et al., 2007; Morrison et al, 1999), pre-term delivery of 
underweight infants (Offenbacher et al., 1996), stroke (Pussinen et al., 2004; Pussinen et 
al., 2007), atherosclerosis and rheumatoid arthritis (Gibson et al., 2006; Miyakawa et al.; 
Morrison et al., 1999). The exact mechanism for the association is unknown but it may be 
due to increased circulating cytokines and mediators, direct infection and cross-reactivity 
or molecular mimicry (Seymour et al., 2007).  
1.2.1 Porphyromonas gingivalis 
 Porphyromonas gingivalis (P. gingivalis) is an anaerobic, gram-negative, non-
motile bacterium of the family Bacteroidaceae. The increase in P. gingivalis abundance in 
the oral microbiome plays a critical role in the development of the chronic inflammatory 
disease known as periodontitis. P. gingivalis is often referred to as a “keystone pathogen” 
in the development of periodontitis (Hajishengallis et al., 2012).  The term “keystone” is 
used to describe the species’ grand impact on its community and structure of the biofilm 
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(Hajishengallis et al., 2012; Power et al., 1996). As shown in Figure 1, P. 
gingivalis, Tannerella forsythia, and Treponema denticola make up the ‘red complex’, 
which is well established to be associated with periodontal disease (Holt & 
Ebersole, 2000; Kumar et al., 2003; Dewhirst et al., 2010).  P. gingivalis’ major role in the 
initiation and progression of periodontitis may be used as a risk indicator for periodontal 
disease (Ezzo et al., 2003).   
 
Figure 1: Pathogens involved in periodontal disease. (Modified from: Haffajee A, 
Sokransky S, “Microbial Goals of Periodontal Therapy”. Periodontology 2000. 
2006;42180-210) 
 
1.3. P. gingivalis Virulence factors 
 P. gingivalis expresses four major virulence factors: fimbriae, capsule, gingipains 
and lipopolysaccharides. The main function of fimbriae is to mediate adhesion and 
invasion into host epithelial cells. P. gingivalis fimbriae modulate proinflammatory 
cytokine production and also induce T cell activation in mice (Isogai et al., 1994).  
 The capsule of P. gingivalis aids in immune evasion, promoting survival of the 
bacterium within host cells and increasing virulence (Singh et al., 2011). Along with 
immune evasion, encapsulation also reduces the host immune response in a variety of 
ways. Phagocytosis is reduced, survival increases in the presence of host cells, dendritic 
cell maturation induced by P. gingivalis is reduced, and virulence of P. gingivalis is 
enhanced compared to non-encapsulated P. gingivalis strains (Singh et al., 2011). 
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P. gingivalis gingipains are proteases that function to degrade proteins into 
peptides as a source of nutrients. P. gingivalis utilizes hemin, iron-containing 
Protoporphyrin IX, as the primary form of iron (Priyadarshini et al., 2013). P. gingivalis 
acquires hemin from hemoglobin via the enzymic activity of gingipains (Priyadarshini et 
al., 2013). Gingipains also contribute to evasion of phagocytosis by degrading serum 
opsonins and host tissues (Genco et al., 1991). There have been three cysteine proteases 
purified from P. gingivalis with site-specific hydrolysis. Two of the proteases hydrolyze 
peptide bonds after Arginine residues and one hydrolyzes peptide bonds after Lysine 
residues. The proteases have recently been referred to as RGP and KGP or “gingipain R” 
and “gingipain K” (Pike et al., 1994). Gingipain R aids in intracellular invasion and 
evasion of the host immune response by mediating vascular permeability through 
bradykinin release, enhancing binding of fimbriae to fibroblasts, and destroying the 
proteins of the complement system (Pike et al., 1994). Gingipain K mediates similar 
activities and is currently described as the most potent fibrinogenase (Pike et al., 1994).  
 In general, gram-negative organisms contain an important amphipathic outer 
membrane component called the lipopolysaccharides (LPS). The LPS enhances structural 
integrity and contributes to the organism’s biological activity (Ezzo et al., 2003). The LPS 
of P. gingivalis has unique properties. Most gram-negative bacteria interact with TLR4 as 
the main transmembrane receptor for lipopolysaccharides, while TLR2 is the main 
receptor to yeasts and gram-positive bacteria. P. gingivalis is an exception in that it can 
interact with TLR2 (Hirschfeld et al., 2001; Pulendran et al., 2001). Surface components 
of P. gingivalis including the LPS, lipoproteins, and fimbriae interact with TLR2 
expressed on the surface of host cells (Takeda & Akira 2004). TLR2 mediates the 
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expression of genes responsible for inflammation (Burns et al., 2006). The activation of 
TLR2 by P. gingivalis LSP may allow the pathogen to be able to regulate the class of the 
immune response in vivo, favoring a humoral response and enhancing its survival (Ezzo et 
al., 2003).  
1.4. Gene Regulation in P. gingivalis 
1.4.1. Riboregulation and RNA-binding proteins in Eubacteria  
 Regulation of protein translation by small non-coding regulatory RNA (sRNA) and 
RNA binding proteins is rapidly becoming a focus in the studies of pathogenic bacteria 
(Phillips et al., 2013). Studies have shown that regulation of protein expression by RNAs 
and their associated proteins is much more widespread than previously thought (Beisel et. 
al 2010). These regulatory RNAs and RNA binding proteins are known as riboregulators. 
RNAs are effective regulatory molecules that can influence protein expression and 
function in response to external signals such as temperature, pH, and metabolite levels 
(Gripenland et al., 2010).  
 Riboregulation is an efficient mechanism for rapidly regulating translation in 
bacteria in diverse environmental conditions. First of all, evidence shows that generating 
riboregulators and target RNAs through transcription requires much less energy than 
translating regulatory proteins (Gripenland et al, 2010). Secondly, riboregulators can 
control translation much faster than regulatory proteins (Gripenland et al, 2010). For 
example, 5’ untranslated regions directly dictate the expression of the downstream mRNA 
(Gripenland et al, 2010). Also, RNAs can rapidly terminate signal by degrading when no 
longer needed since they are usually much less stable than proteins. Lastly, many 
riboregulators can act post-transcriptionally to modify mRNAs (Gripenland et al, 2010).  
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 The riboregulators can work in a variety of ways. Cis-acting RNAs are expressed 
from the opposite DNA strand and act in an antisense manner to control translation of 
mRNAs (Gipenland et al., 2010).  Trans-acting small non-coding RNAs, sRNAs are 
expressed from a different location on the chromosome and act at a distance to regulate 
RNA translation in an antisense manner (Waters et al., 2009). Bacterial sRNAs typically 
range in length from about 50 to 300 nucleotides (De lay N et al., 2013). Bacterial sRNAs 
and RNA-binding proteins bind to target mRNA by imperfect base pairing, dependent on 
the sRNA's secondary structure (Phillips et al., 2014). As depicted in Figure 2, Base 
pairing can lead to stabilization and translational activation of target mRNA (De lay N et 
al., 2013). Typically, activation occurs when the sRNA or RNA-binding protein base pairs 
within the 5′-UTR, leading to a conformational change of the 5′-UTR, exposing the 
ribosome-binding site to allow entry of the ribosome and translation to occur (Fröhlich et 
al., 2009; Gottesman, 2011).  Alternatively, the action of sRNAs and RNA-binding 
protein may lead to translational repression and degradation of the target mRNA (De lay 
N et al., 2013). In most cases that have been characterized, sRNAs or RNA-binding 
proteins base pair on or near the ribosome-binding site of a target mRNA, leading to 
inhibition of translational initiation and, usually, the subsequent destabilization of the 
target mRNA (De lay N et al., 2013).  
   7 
 
Figure 2: RNA-binding protein interaction with mRNA. When RNA-binding protein 
(RBP) binds to messenger RNA (mRNA) and changes its conformation to expose the 
ribosome-binding site (RBS), translation is enhanced. (B.) RBP can bind to the mRNA 
and hide the RBS, thus inhibiting translation.   
 
 
1.4.2. Accessory RNA-Binding Proteins 
Also, RNA-binding proteins often bind to the sRNA as an accessory protein. 
Illustrated in Figure 3, accessory proteins interact with the sRNAs to stabilize the RNA, 
facilitate sRNA-mRNA binding, or degrade the RNA—adding another level of regulation.  
So far, the accessory proteins have been classified as either chaperones or RNases. 
Molecular chaperones are proteins that bind to the RNA and assist in folding or unfolding. 
Trans-acting sRNAs often require a chaperone protein for stability and to facilitate 
binding with the target mRNA (Beisel et al., 2010; Waters et al., 2009; Soper et al., 2008).  
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Figure 3: RNA-binding protein (RBP) interaction with sRNA to stabilize sRNA and 
to enhance binding of sRNA to mRNA to regulate gene expression. (A.) When sRNA-
RBP complex binds to mRNA and changes its conformation to expose the RBS, 
translation is enhanced. (B.) When the sRNA-RBP complex binds to the mRNA and hides 
the RBS, translation is inhibited.  
 
A well studied and common RNA binding protein known as Hfq has been found in 
about half of bacteria and functions as a chaperone for sRNAs. The chaperone protein Hfq 
in E. coli facilitates the binding of stable trans-acting sRNA with the target mRNA target 
(Gripenland et al, 2010). Hfq has been shown to participate in virulence in many gram-
negative bacteria (Gripenland et al, 2010).  
 RNases are enzymes that govern the maturation and degradation of target mRNAs 
and trans-acting sRNAs (Anderson et al, 2009). Endonucleases cleave within the 
transcript, and exonucleases cleave at the 5’ or 3’ ends of the transcripts (Gripenland et 
al., 2010).  
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1.4.3. HU Nucleoid-associated proteins  
HU protein is one of the most abundant nucleotide-associated proteins (NAPs) in 
the bacterial cell. HU binds to nicked or gapped DNA–RNA hybrids and to small non-
coding RNA molecules (Balandina et al., 2002). HU has been shown to compact and 
prevent denaturation of DNA under harmful conditions (Drlica & Rouviere-Yaniv, 
1987; Oberto et al., 2009; Swinger & Rice, 2004) and to be involved in changing DNA 
topology specifically by introducing negative super coiling into relaxed DNA in the 
presence of topoisomerase I. HU acts as an accessory protein in most types of 
nucleoprotein-mediated processes (Drlica & Rouviere-Yaniv, 1987; Grove, 2011), such 
as acting as a cofactor to either stimulate or repress transcription (Aki et al., 
1996; Morales et al., 2002) or aiding in translation (Balandina et al., 2001).  
It was found that HU binds to RNA just as it does to supercoiled DNA, previously 
believed to be the major target for the nucleoid-associated HU (Rouviere-Yaniv et al., 
Balandina et al., 2002). Contrary to previous beliefs, HU has recently been recognized to 
bind with high affinity to mRNA from rpoS. This gene encodes the stress sigma factor of 
RNA polymerase, stimulating its translation (Balandina et al., 2001).   
1.5. Mechanisms of regulation in P. gingivalis 
The dynamic environment and host immune responses cause stress to the 
organisms residing in the oral cavity. In order to survive and thrive in a hostile 
environment, P. gingivalis has to monitor its surroundings and adjust its gene expression.  
 P. gingivalis scavenges for essential nutrients in the oral cavity; iron in particular is 
crucial for establishment and progression of infections (Wooldridge et al., 1993). Studies 
assessing gene expression profiles of P. gingivalis strain W83 support the notion that there 
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is a regulatory switch that initiates periodontal pathogenesis during mid-log phase under 
hemin limitation (Kiyama-Kishikawa et al., 2005). The regulatory systems used by P. 
gingivalis to rapidly respond to these and other environmental cues remain unclear 
(Phillips et al., 2013). 
Transcriptional regulatory mechanisms reported in P. gingivalis include the two-
component system (Hasegawa et al., 2003; Nishikawa & Duncan, 2010), extracytoplasmic 
function (ECF) sigma factor (Dou et al., 2010; Yanamandra et al., 2012), and transposase-
mediated regulation (Lewis et al., 2009).    
(i) Two-component system 
In P. gingivalis the first two-component system identified was FimS–FimR 
(Hayashi et al., 2000). In this regulatory mechanism (Fig. 4), an unknown environmental 
signal is received by the FimS sensor kinase and transmitted to the associated FimR 
response regulator in the cytoplasm. The activated FimR up-regulates the transcription of 
the fimX–pgmA operon, followed by the expression of fimA, encoding a major subunit 
fimbrilin (FimA), in a FimX-dependent manner.  Finally, the expressed FimA acts as a 
positive regulator for the transcription of downstream genes encoding minor structural 
components (Yoshimura et al., 2009).  
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Figure 4: Schematic representation of P. gingivalis two-component system regulatory 
mechanism FimS–FimR. (Figure adapted from Yoshimura et al., 2009) 
 
(ii) Extracytoplasmic function (ECF) sigma factor  
 P. gingivalis responds to environmental signals by regulating at the level of 
transcription initiation involving alternative sigma factors. Sigma factors recruit RNA 
polymerase and facilitate specific promoter recognition and transcription initiation (Paget 
& Helmann, 2003). The P. gingivalis W83 genome encodes eight sigma factors, six of 
which belong to the ECF sigma factor subfamily (PG0162, PG0214, PG0985, PG1318, 
PG1660, and PG1827) (Nelson et al., 2003).  Several of the ECF sigma factors may play a 
role in virulence regulation and adaptation to oxidative stress.  ECF sigma factors encoded 
by the PG0162 and PG1660 genes are likely involved in the post-transcriptional 
regulation of the gingipains (Dou et al., 2010). 
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(iii) Transposase-mediated regulation 
 Bacterial insertion sequences (IS) can mediate genetic effects in their host cells. 
They are able to inactivate single genes by insertion and creation of mutations via 
transposition.  Insertion sequences can inactivate multiple genes due to polarity effects 
(Galas and Chandler, 1989). Transposition can also cause transcriptional activation of 
dormant genes by outward-firing IS promoters or by creation of new promoters resulting 
from the insertion event (Podglajen et al., 1995).  Insertion sequences may facilitate 
genomic rearrangements such as deletions and inversions by acting as sites for 
homologous recombination or as the result of their mobility (Lewis and Macrina, 1998). 
  Transposition might function as a means to control virulence gene expression 
in P. gingivalis, particularly in the case of protease gene inactivation. Lewis and Macrina 
investigated the sequence IS195 interrupting the prtP gene and concluded that it was a 
novel IS-like element (Lewis and Macrina, 1998).   
(iv) Riboregulation in P. gingivalis 
 There is significant work suggesting that sRNA-mediated post-transcriptional 
regulation is a conserved mechanism among pathogenic bacteria to modulate bacterial 
virulence and survival. In one particular study, P. gingivalis sRNA expression profiles 
were generated in response to growth phase, hemin availability after hemin starvation, or 
both (Phillips et al., 2014). By employing RNA-seq analysis to identify and characterize 
the expression profile of small RNA transcripts expressed in P. gingivalis, a list of 
possible regulatory transcripts was generated.   The study identified highly expressed 
transcripts of sRNAs, some of which are hypothesized to be involved in genetic exchange 
using transposition. Overall, this approach provided a comprehensive way to examine 
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transcriptional activity to investigate RNA transcripts involved in responding to 
environmental signals (Phillips et al., 2014).  
Most sRNAs currently characterized in bacteria are stabilized by Hfq. Hfq is a 
chaperone conserved across many bacterial species (Beisel & Storz, 2010; Richards & 
Vanderpool, 2011; Storz et al., 2011; Vanderpool et al., 2011; Bossi et al., 2012; Richter 
& Backofen, 2012; Sobrero & Valverde, 2012). However, P. gingivalis is among the 50% 
of bacteria known as an Hfq-negative bacterium, and its sRNA regulatory system is 
currently uncharacterized. As of yet, there is no RNA-binding protein identified in P. 
gingivalis. Among the bacterial species implicated as aetiological agents of periodontal 
disease, P. gingivalis is most intensely investigated, and therefore has been chosen as a 
model for pathogen riboregulation in the oral cavity (Lewis, 2010).   
1.6. Candidates for P. gingivalis RNA Binding Proteins (RBPs) 
(i) RBP (PG0565, PG0627) 
 RBP is a putative RNA-binding protein in P. gingivalis based on bioinformatics. 
The BROP program shows numerous significant hits in BLAST to other RNA-binding 
proteins (Table 1). Also, unpublished data from the Lewis lab has shown that RBP 
knockouts cannot survive the innate immune responses of eukaryotic cells. 
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Table 1: Candidate Protein RBP information (Oralge database: 
http://www.oralgen.org/cgibin/gene_id_search.cgi?dbname=pgin&gene_id=PG0565) 
 
LANL Gene ID PG0565 
GenBank Locus Tag PG0627 
DNA Molecule 
Name 
1 
GenBank ID 34540433 
Definition  RNA binding protein 
Cellular location Cytoplasm 
Gene Start 681526 
Gene Stop 681236 
Gene Length 291 
Molecular Weight 11,484 
pI 5.40 
Net Charge -1.76 
Functional Class Transcription 
Blast Summary Numerous significant hits in gapped BLAST to RNA binding 
protein.  
Residues 1-76 are 53% similar to gbAAC65342.1 RNA-binding 
protein, putative of Treponema pallidum. 
Residues 3-76 are 54% similar to gbAAA85379.1 RNA binding 
protein of Synechocystis sp. 
Residues 1-76 are 50% similar to gbAAC47624.1 putative RNA 
binding protein of Brugia malayi. 
 
RBP Amino Acid Sequence: 
MSMNIYVGNLNYRVREEDLTGLLQQYGAVTSARVITDRETGRSRGFGFVE 
MEDENDARRAIEELFDQEFQGRKLIVKEALERPERAPRRTFRHEDRY 
 
Figure 5: Locus of RBP (PG0565) in P. gingivalis genome. (Oralgen.org) 
 
 
 
   15 
1.6.1. HU Proteins in P. gingivalis  
The genome of P. gingivalis is predicted to encode both the HUα (PG1258) and 
the HUβ (PG0121) subunit (Table 2 and 3). There are twelve genes in the P. gingivalis 
W83 genome that are annotated by BROP databse as histone-like DNA-binding proteins 
that are related to HU, but some are longer and have distinct domain architecture. These 
proteins have a separate superfamily known as TIGR1201. 
(ii) HUβ (PG0106, PG0121)  
The gene PG0121 encodes a functional homologue of E. coli HU and shares 76.7% 
sequence similarity to E. coli HUβ (Pearson & Lipman, 1988; Priyadarshini et al., 2013). 
Also, HUβ from the P. gingivalis genome has the ability to complement some HU 
functions in E. coli HU double mutants (Priyadarshini et al., 2013).  
HUβ has global regulatory functions in P. gingivalis and is differentially expressed 
at the level of transcription during different phases of growth (Priyadarshini et al., 
2013). HUβ affects surface polysaccharides production for capsule synthesis and also 
expression of genes involved in basic functions such as cell division, iron uptake, cell wall 
synthesis, translation and DNA binding (Priyadarshini et al., 2013).  The expression of the 
K-antigen capsule operon may be regulated by HUβ’s interaction with RNA structures, 
but the ability of HUβ to bind to RNA has not been tested (Tjokro et al., 2014). In E. coli, 
HU has been shown to bind upstream of rpoS mRNA, which encodes the RNA 
polymerase stress sigma factor. This binding results in increased RpoS protein expression 
(Balandina et al., 2001).  It is hypothesized that the expression of the K-antigen capsule is 
regulated by a similar mechanism (Tjokro et al., 2014).  
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Table 2: Candidate RNA-binding protein HUβ information (Oralgen database: 
http://www.oralgen.org/cgi-bin/gene_id_search.cgi?dbname=pgin&gene_id=PG0106) 
 
LANL Gene ID PG0106 
GenBank Locus Tag PG0121 
DNA Molecule Name 1 
GenBank ID 34539986 
Definition  DNA-binding protein (HU-related) 
Cellular location Cytoplasm, Periplasm 
Gene Start 144608 
Gene Stop 144871 
Gene Length 264 
Molecular Weight 9461 
pI 11.00 
Net Charge 7.98 
Functional Class DNA metabolism; chromosome-associated proteins 
Blast Summary Numerous significant hits to DNA-binding protein in gapped 
BLAST. 
Residues 1-86 are 54% similar to dbj|BAA07273.1| DNA 
binding protein HU of Bacillus stearothermophilus. 
Residues 1-86 are 54% similar to dbj|BAB05028.1| non-specific 
DNA-binding protein II (HB) (HU) of Bacillus halodurans. 
Residues 1-86 are 51% similar to pir||DNZRH3 DNA-binding 
protein of Rhizobium leguminosarum. 
 
 
 
HUβ  Amino Acid Sequence: 
MNKTDFIAAVAEKANLTKADAQRAVNAFAEVVTEQMNAGEKIALIGFGTF 
SVSERAARKGINPKTKKSISIPARKVVRFKPGSTLELK 
 
Figure 6: Locus of HUβ (PG0106) in P. gingivalis genome. (Oralgen.org) 
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(iii) HUα (hup, PG1258) 
 Previous studies indicate that HUα is essential for growth in P. gingivalis strain 
W83 (Alberti-Segui et al., 2010; Klein et al., 2012). The P. gingivalis gene PG1258 has 
been shown to encode a homolog of E. coli HUα (Tjokro et al., 2014). The P. gingivalis 
HUα shares 71.1% amino acid similarity to E. coli HUα (Peason & Lipman, 1988).  In 
other organisms HUα will compensate for the lack of HUβ, but in a study using P. 
gingivalis with deletion of PG0121, microarray and qRT-PCR data indicated that 
transcription of PG1258 is not significantly altered in the PG0121 HU mutant 
(Priyadarshini et al., 2013).  These results indicate that HUα may not play a compensatory 
role in P. gingivalis (Priyadarshini et al., 2013).   P. gingivalis HUα may play an 
important role in ensuring proper function of HUβ, but further studies are required in order 
to confirm the role of HUα in a heterodimer and to more thoroughly understand the 
function of HUα (Tjokro et al., 2014).  
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Table 3: Candidate RNA-binding protein HUα information (Oralgen database: 
http://www.oralgen.org/cgi-bin/gene_id_search.cgi?dbname=pgin&gene_id=PG1111) 
 
LANL Gene ID PG1111 
GenBank Locus Tag PG1258 
DNA Molecule Name 1 
GenBank ID 34540963 
Gene name hup  
Definition  histone-like DNA binding protein, IHFA, IHFB, or DBH 
Cellular location Cytoplasm, Periplasm 
Gene Start 1334955 
Gene Stop 1334680 
Gene Length 274 
Molecular Weight 10282 
pI 10.40 
Net Charge 4.99 
Functional Class DNA metabolism; DNA replication, recombination and repair 
Blast Summary Numerous significant and weak hits to DNA-binding protein in 
gapped BLAST. 
Residues 1-90 are 38% similar to dbj|BAA07273.1| DNA 
binding protein HU of Bacillus stearothermophilus. 
Residues 1-83 are 42% similar to pir||JC1208 DNA-binding 
protein HU of Bacillus subtilis. 
Residues 1-83 are 40% similar to dbj|BAB05028.1| non-specific 
DNA-binding protein II (HB) (HU) of Bacillus halodurans. 
 
HUα  Amino Acid Sequence: 
MTKADVVNAIAKSTGIDKETTLKVVESFMDTIKDSLSEGDNVYLRGFGSF 
IVKERAEKTARNISKQTTIIIPKRNIPAFKPSKIFMSQMKQD 
 
Figure 7: Locus of HUα (hup, PG1258) in P. gingivalis genome. (Oralgen.org) 
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CHAPTER 2: HYPOTHESIS AND AIMS 
 
2.1. Hypothesis 
We hypothesize P. gingivalis candidate proteins RBP (PG0565), HUβ (PG0121) 
and HUα (PG1258) bind to RNA in P. gingivalis. 
2.2. Research Objective and Aims 
 The main objective of this research work is to investigate the interaction of the 
candidate proteins: RBP (PG0565), HUβ (PG0121) and HUα (PG1258) with RNA in P. 
gingivalis. Flowchart illustrating our work plan is shown in Fig. 8. 
Aim 1: To test the binding of candidate proteins RBP (PG0565), HUβ (PG0121) and HUα 
(PG1258) with RNA using:  
I. Preparation of recombinant proteins 
II. Electophoretic Mobility Shift Assays (EMSA) using labeled and 
competitor RNA 
III. EMSA using synthesized RNA strands with specific motifs 
Aim 2: To isolate the P. gingivalis W83 RNA bound to RBP (PG0565), HUβ (PG0121) 
and HUα (PG1258), and to sequence the RNA using: 
I. Pulldown assay to isolate the protein-RNA complexes 
a. His-tag Pulldown 
b. HaloTag Pulldown  
II. RNA sequencing and library generation of P. gingivalis W83 RNA  
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Figure 8: Flowchart of the project aims and methods 
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CHPATER 3: MATERIALS AND METHODS 
 
3.1.  Bacterial Strains and Plasmids 
The bacterial strains and plasmids used in this study are listed in Table 4. 
Table 4:  Bacterial strains and plasmids used in this study 
 Strain Plasmid Description Reference 
Top10 pCR2.1-
TOPO 
Kanamycin resistance 
Ampicillin resistance 
Invitrogen 
α-Select 
Silver 
pET-30a His-Tag 
Kan coding sequence 
Bioline 
pET-30a His-Tag  
Kan coding sequence 
Novagen 
E. coli 
BL21 
pFC20K HaloTag T7 SP6 Flexi 
Vector 
Kanamycin resistance 
Promega 
P. gingivalis W83 Parental 
Strain 
 Lewis et al., 
1998 
 
3.2. Media Growth Conditions 
I. Escherichia coli  
 Escherichia coli (E. coli) was grown aerobically at 37 °C in Luria-Bertani (LB) 
broth (Invitrogen; cat. no. 12780029) or on LB agar. Kanamycin (50 µg/mL) was added to 
select for recombinant strains. 
II. Porphyromonas gingivalis 
 Porphyromonas gingivalis (P. gingivalis) strain W83 was grown anaerobically at 
an atmosphere of 10% H2, 10% CO2 and 80% N2 at 37°C. Bacteria liquid cultures were 
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prepared in Brain-Heart infusion broth (BHI; Difco Laboratories, Detroit, Mi) with hemin 
(5 µg/mL; Sigma, St. Louis, MO), yeast extract (5 mg/mL) cysteine (1mg/mL; Sigma, St. 
Louis, MO) and vitamin K3 (1 µg/mL; Sigma, St. Louis, MO). 
3.3. Creating recombinant RBP, HUβ , and HUα  with His-Tag 
3.3.1 PCR amplification of genes PG0565, PG0121, and PG1258 
 PCR was performed using PCR SuperMix (Invitrogen) to amplify gene PG0565, 
PG0121, and PG1258. 35 cycles were performed of denaturing at 94°C for 30 sec, 
annealing at 52 °C for 30 sec, and extending at 72°C for 3 min. Gel electrophoresis was 
used to confirm the size of the amplified fragment. The PCR product was then extracted 
from gel using Qiagen Mini Elute PCR Purification Kit (Qiagen).  
RBP primers: 
1F:  CGA GGC CAT GGC TAT GAG TAT GAA CAT CTA CGT AG 
1R: GCG TGC TCG AGT CAA TAG CGA TCT TCG TGT CGG 
HUβprimers: 
2F: CGA GGC CAT GGC TAT GAA CAA GAC AGA TTT TAT TGC AG 
2R: GGT GCT CGA GTT ACT TAA GTT CCA AAG TAG AGC 
HUα  primers: 
3F: CGA GGC CAT GGC TAT GAC GAA AGC TGA CGT AGT GAA CG 
3R: GGT GCT CGA GTT AGT CTT GTT TCA TCT GAC TC 
3.3.2 Cloning and Transformation 
Purified PCR product of amplified gene PG0565, PG0121, and PG1258 were 
cloned using TA cloning kit into vector pCR2.1-TOPO (Invitrogen) illustrated in Figure 9.  
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Figure 9: Diagram of vector pCR2.1-TOPO (adapted from Invitrogen). 
The vector was transformed into Top10 cells (Invitrogen) using the heat shock 
method. IPTG and x-gal were used when plating to screen for recombinant colonies. 
Overnight cultures were prepared from white colonies and plasmids were purified using 
the Q1prep Spin Miniprep Kit (Qiagen; cat. no. 27104). Colonies were screened using 
restriction enzyme EcoRI digest. The inserts and vector pET-30a were digested using 
restriction enzymes NcoI and XhoI, and electrophoresed on 1% agarose gel. The gene 
inserts PG0565, PG0121, and PG1258 and the pET-30a vector were isolated using a gel 
extraction kit, (Qiagen, Mini Elute Gel Extraction Kit). PG0565, PG0121, and PG1258 
gene inserts were ligated into pET-30a (Novagen; Fig. 10) using T4 DNA Ligase (New 
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England Biolabs) and transformed into α-Select Silver E. coli (Bioline). The 
transformations were screened on LB plates with kanamycin and colonies were cultured 
overnight in 20mL of LB media. 
 
Figure 10: Diagram of pET-30a vector (adapted from Novagen). Restriction enzymes 
used for insertion: XhoI and NcoI. The “kan” designates a gene encoding kanaycin 
resistance that in turn allows for colony selection using kanamycin. 
 
Overnight cultures were prepared and plasmids were purified using the Q1prep 
Spin Miniprep Kit (Qiagen; cat. no. 27104). Insert was verified using restriction enzymes 
NcoI and XhoI. The pET-30a plasmid with insert was purified using the QIAprep Spin 
Miniprep Kit (Qiagen; cat. no. 27104). The plasmids were then transformed into BL21 
competent E. coli cells for protein expression using the heat shock method. 
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3.3.3. Creating recombinant RBP with C-Terminal His-Tag 
3.3.4. PCR Amplification of PG0565 
PCR was performed to amplify gene PG0565, and then purified using Qiagen Mini 
Elute PCR Purification Kit.  
Primers: 
F1 new: 
CTT CCA GGG ATC CCC AGA ATT CGA TCT TCT TCT GAA AGC CTG 
CGA GGC CAT GGC TAT GAG TAT GAA CAT CTA CGT AG 
R1 new: 
GCG CAC TCG AGT TAC TCC AGC CTC GAC AAT CGG 
Purified PCR product of gene PG0565 cloned using TA cloning kit into vector 
pCR2.1-TOPO (Invitrogen; Fig. 9). The vector was transformed into Top10 cells 
(Invitrogen) and selected for with IPTG and x-gal used to screen for recombinant colonies. 
Overnight cultures were prepared from white colonies and plasmids were purified using 
the Q1prep Spin Miniprep Kit. Colonies were screened using restriction enzyme EcoRI 
digest. The insert and pET-30a (Fig. 10) were digested using restriction enzymes NdeI and 
XhoI, and electrophoresed on 1% agarose gel. The insert containing gene PG0565 and 
vector pET-30a were isolated using a gel extraction kit, (Qiagen, Mini Elute Gel 
Extraction Kit). The insert was then cloned into pET-30a vector (Novagen) using T4 DNA 
Ligase and transformed into α-select Silver competent cells (Bioline) using heat shock 
technique.  
Overnight cultures were prepared and plasmids were purified using the Q1prep 
Spin Miniprep Kit. Insert was verified using restriction enzymes NdeI and XhoI. The pET-
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30a plasmid with insert was purified using the QIAprep Spin Miniprep Kit (Qiagen; cat. 
no. 27104). The plasmids were then transformed into BL21 competent E. coli cells) using 
heat shock technique. 
 
3.3.5. Creating recombinant RBP, HUβ, and HUα with Halo-Tag  
 Other members in the lab had prepared pFC20K HaloTag plasmids (Fig. 11) 
pFC20K-RBP, pFC20K-HUβ, and pFC20K-HUα.  
 
Figure 11: pFC20K HaloTag Diagram (adapted from Promega). Gene insertion replaces 
lethal gene named barnase to create recombinant plasmids: pFC20K-RBP, pFC20K-HUβ, 
and pFC20K-HUα. 
 
Barnase is a lethal gene that is replaced when the gene of interest is inserted into the 
plasmid.  The Halotag is used to bind covalently to Halotag resin to purify recombinant 
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protein. The TEV site is the cleavage site of the protease to release recombinant protein 
from the resin during purification.  The Kan’ designates a gene encoding kanaycin 
resistance that in turn allows for colony selection using kanamycin.  
The plasmids were then transformed into BL21 cells using the heat shock technique, 
plated on Kan LB agar plates, and incubated overnight at 37°C.  
3.4. Purification of recombinant proteins by affinity chromatography  
3.4.1 His-Tag Purification of RBP, HUβ , and HUα  
 1L BL21 cell cultures in LB media were induced with IPTG at OD of 0.6 and 
incubated overnight at 37°C. Cultures were centrifuged into pellets and re-suspended in 
binding buffer. Binding buffer contained 50 mM Na2HPO4, 300 mM NaCl, and 10 mM 
imidazole (IMD) at pH 8.0.  Cells were lysed using lysozyme and sonication techniques, 
centrifuged, and supernatant was saved. Ni-NTA agarose (Qiagen; cat. No. 30210) was 
added to lysate to conduct His-tagged purification by gravity-flow chromatography. The 
Ni column was washed with 100mL wash buffer. Wash buffer contained 50 mM 
Na2HPO4, 300 mM NaCl, and 20 mM IMD. His-tagged proteins were eluted using an 
elution buffer that contained 50 mM Na2HPO4, 300 mM NaCl, and 250 mM IMD. 
Elutions were collected and run on NuPAGE® 12% Bis-Tris precast gel (Life 
technologies).  
3.4.2. Size Exclusion chromatography of RBP  
RBP was further purified using size exclusion high performance liquid 
chromatography (SE-HPLC). The flowthrough from the Ni-agarose column purification 
was applied to the SE-HPLC and aliquots were collected and analyzed using SDS-PAGE 
analysis.  
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3.4.3. Purification of C-terminal His-Tagged RBP  
 1L BL21 cell culture was induced with IPTG at OD of 0.6 and incubated overnight 
at 37°C. Cultures were centrifuged into a pellet and re-suspended in binding buffer. 
Binding buffer contained 50 mM Na2HPO4, 300 mM NaCl, and 10 mM IMD at pH 8.0.  
Cells were lysed using lysozyme and sonication techniques, centrifuged, and supernatant 
was saved.  Ni-NTA agarose (Qiagen; cat. No. 30210) was added to lysate to conduct His-
tagged purification by gravity-flow chromatography. Column was washed with 100mL 
wash buffer. Wash buffer contained 50 mM Na2HPO4, 300 mM NaCl, and 20 mM IMD. 
His-tagged protein was eluted using an elution buffer that contained 50 mM Na2HPO4, 
300 mM NaCl, and 250 mM IMD. Elutions were collected and run on NuPAGE® 12% 
Bis-Tris precast gel (Life technologies).  
3.4.4. His-Tag Repurification on Dynabeads 
 The RBP, HUα, and HUβ from his-tag column purifications were dialyzed in 
binding buffer overnight at 4°C. Binding buffer contained 50 mM Na2HPO4, 300 mM 
NaCl, and 10 mM Imidazole at pH 8.0.  The proteins were then applied to the Dynabeads 
and let incubate for 1hr at 4°C. The beads were placed on a magnet separation device, and 
supernatant was decanted.  The beads were then washed with nuclease free binding buffer, 
placed on a magnet and supernatant decanted. The wash process was repeated 4 times. The 
proteins were eluted using nuclease free elution buffer containing 50 mM Na2HPO4, 300 
mM NaCl, and 300mM IMD at pH 8.0. The proteins were then dialyzed in nuclease free 
binding buffer overnight at 4°C.  
3.4.5. HaloTag Protein Isolation 
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BL21 colonies were selected and cultured in Kan LB broth. 80mL BL21 cell 
cultures were induced with IPTG at OD of 0.6 and incubated overnight at 37°C. After the 
cell cultures were induced, they were centrifuged, and media was disposed. The cell pellet 
was washed with Purification Buffer, which contains 8.75 g/L NaCl, 11.9 g/L Hepes, and 
1mM TCEP. The pellet was resuspended in 18 mL of purification buffer. 2 mL CelLytic B 
reagent (Sigma-Aldrich) was added to the suspension and incubated for 20 minutes.  The 
cell lysates were spun down at 12,000 RPM for 15 minutes. 
To equilibrate the Halo link resin, the resin was mixed well and 1mL per 250mL 
original culture was added to a clean falcon tube. 20 mL of nuclease free purification 
buffer was added to the resin and spun at 2,000 RPM for 2 minutes. The buffer was 
removed by pipetting and repeated 2 more times.  
The cell lysate was applied to the resin and incubated at for 45 minutes at room 
temperature on a rocker. The resin-tagged protein was then washed with 20 mL RNase 
free pulldown buffer that contained 3.25 mM Sodium phosphate and 70 mM NaCl, pH 
7.4, and centrifuged at 2,000 RPM for 2 minutes. The wash was repeated 2 more times. 3 
mL was left in the tube after the final wash. 100 µL TEV mix was added to each sample 
and incubated overnight at 4°C to release the protein from the covalent bond.  
3.5. Electrophoretic Mobility Shift Assay 
3.5.1 Binding Reactions  
 The Light Shift® Chemiluminescent RNA EMSA Kit was used to perform gel 
shift assays for the three candidate proteins. The control RNA used in this kit is an Iron 
response element (IRE) RNA.  IRE is RNA with hairpin structure found in untranslated 
regions (UTRs) of various mRNAs that encode proteins involved in control of iron 
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metabolism (Piccinelli & Samuelsson, 2007). The positive control included in this kit is 
cytosolic liver extract. The protein in cytosolic liver extract that binds RNA is the 
cytosolic aconitase. Cytosolic aconitase is an IRE-binding protein which may regulate 
translation of mitochondrial aconitase mRNA (Zheng et al., 1992). The binding reactions 
were assembled according to protocol in the order listed in Tables 5, 6 and 7 on ice. 
Reactions were incubated on ice for 30 minutes.  
Biotinylated IRE Control RNA (125nM):  
5’ –UCCUGCUUCAACAGUGCUUGGACGGAAC—3’ –Biotin  
Unlabeled IRE Control RNA (10 µM): 
5’ –UCCUGCUUCAACAGUGCUUGGACGGAAC—3’ 
Synthesized Biotin Labeled RNA Probes: 
Long : 
5'- rGrGrG rGrArU rUrGrC rArCrG rUrUrU rUrUrU rUrUrU rUrGrC rArUrG 
rUrUrU rUrUrU rUrUrG rUrGrU rGrUrU rArUrU rGrCrA rCrGrG rGrGrG rGrGrG 
rG/3Bio/ -3' 
 
Short: 
5'- rUrUrG rGrUrU rUrUrA rUrUrG rCrUrU rUrGrC rArC/3Bio/ -3’ 
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Table 5: Binding reaction 1 using IRE control RNA from The Light Shift® 
Chemiluminescent RNA EMSA Kit 
 Final 
Amount 
Control 
#1 
Control 
#2 
Control 
#3 
 #4 #5  #6 #7 
Nuclease 
Free Water 
(µL) 
--- 14.8 12.8 10.8  4.8 2.8  4.8 2.8 
10X 
REMSA 
Binding 
Buffer (µL) 
1X 2 2 2  2 2  2 2 
50% 
Glycerol 
(µL) 
5% 2 2 2  2 2  2 2 
tRNA 
(10mg/mL) 
(µL) 
2 µg 0.2 0.2 0.2  0.2 0.2  0.2 0.2 
Unlabeled 
IRE RNA 
(µL) 
1 µM --- --- 2  --- 2  --- 2 
Cytosolic 
Liver 
Extract 
(µL) 
4 µg --- 2 2 RBP  
(µL) 
10 10 HUβ   
(µL) 
10 10 
Biotin—
IRE 
Control 
RNA (µL) 
6.25 nM 1 1 1  1 1  1 1 
 Final 
Amount 
#8 #9  #10 #11 
Nuclease 
Free Water 
(µL) 
--- 4.8 2.8  11.8 9.8 
10X 
REMSA 
Binding 
Buffer (µL) 
1X 2 2  2 2 
50% 
Glycerol 
(µL) 
5% 2 2  2 2 
tRNA 
(10mg/mL) 
(µL) 
2 µg 0.2 0.2  0.2 0.2 
Unlabeled 
IRE RNA 
(µL) 
1 µM --- 2  --- 2 
HUα  (µL)  10 10 Lysozyme 
(µL) 
3 3 
Biotin—
IRE 
Control 
RNA (µL) 
6.25 nM 1 1  1 1 
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Table 6: Binding reaction 2; dose dependent binding reactions of RBP using IRE 
control RNA from The Light Shift® 
 Final 
Amount 
#1 #2 #3 
Nuclease Free 
Water (µL) 
--- 14.8 12.3 9.8 
10X REMSA 
Binding Buffer 
(µL) 
1X 2 2 2 
50% Glycerol (µL) 5% 2 2 2 
tRNA (10mg/mL) 
(µL) 
2 µg 0.2 0.2 0.2 
Unlabeled IRE 
RNA (µL) 
1 µM --- --- 2 
Cytosolic Liver 
Extract (µL) 
4 µg --- 2 2 
Biotin—IRE 
Control RNA (µL) 
6.25 nM 1 1 1 
  #4 #5 #6 #7 #8 
Nuclease Free 
Water (µL) 
--- 14.3 12.8 10.3 5.3 0.3 
10X REMSA 
Binding Buffer 
(µL) 
1X 2 2 2 2 2 
50% Glycerol (µL) 5% 2 2 2 2 2 
tRNA (10mg/mL) 
(µL) 
2 µg 0.2 0.2 0.2 0.2 0.2 
Unlabeled IRE 
RNA (µL) 
1 µM --- --- --- --- --- 
RBP (µL)  1 2.5 5 10 15 
Biotin—IRE 
Control RNA (µL) 
3.12 nM 0.5 0.5 0.5 0.5 0.5 
  #9 #10 #11 #12 #13 
Nuclease Free 
Water (µL) 
--- 12.3 10.8 8.3 3.3 0 
10X REMSA 
Binding Buffer 
(µL) 
1X 2 2 2 2 2 
50% Glycerol (µL) 5% 2 2 2 2 2 
tRNA (10mg/mL) 
(µL) 
2 µg 0.2 0.2 0.2 0.2 0.2 
Unlabeled IRE 
RNA (µL) 
1 µM 2 2 2 2 2 
RBP (µL)  1 2.5 5 10 15 
Biotin—IRE 
Control RNA (µL) 
3.12 nM 0.5 0.5 0.5 0.5 0.5 
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Table 7: Binding Reaction 3 using RBP and synthesized biotinylated RNA probes 
 Final 
Amount 
#1 #2 #3 #4 #5 
Nuclease Free 
Water (µL) 
--- 14.8 12.3 9.8 4.8 0 
10X REMSA 
Binding Buffer 
(µL) 
1X 2 2 2 2 2 
50% Glycerol (µL) 
 
5% 2 2 2 2 2 
tRNA (10mg/mL) 
(µL) 
2 µg 0.2 0.2 0.2 0.2 0.2 
RBP (µL) 
 
 --- 2.5 5 10 15 
Biotin Labeled 
LongProbe (µL) 
 1 1 1 1 1 
  #6 #7 #8 #9 #10 
Nuclease Free 
Water (µL) 
--- 14.8 12.3 9.8 4.8 0 
10X REMSA 
Binding Buffer 
(µL) 
1X 2 2 2 2 2 
50% Glycerol (µL) 5% 2 2 2 2 2 
tRNA (10mg/mL) 
(µL) 
2 µg 0.2 0.2 0.2 0.2 0.2 
RBP (µL)  --- 2.5 5 10 15 
Biotin Labeled 
Short Probe (µL) 
 1 1 1 1 1 
  #11 #12 
Nuclease Free 
Water (µL) 
 11.8 11.8 
10X REMSA 
Binding Buffer 
(µL) 
1X 2 2 
50% Glycerol (µL) 5% 2 2 
tRNA (10mg/mL) 
(µL) 
2 µg 0.2 0.2 
Lysozyme (µL)  3 3 
Biotin Labeled 
Probe (µL) 
 1 µL 
Long 
1 µL 
Short 
 
 
3.5.2. Electrophoresis of Binding Reactions 
 5 µL of 5X loading buffer was then added to each of the reactions. The wells of the 
Novex® TBE 10% gel were flushed with cold nuclease free 1X TBE buffer.  20 µL of 
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each sample was loaded onto Novex® TBE 10% gel and run at 100V at 4°C until the dye 
has run two thirds of the way down the gel.  
3.5.3. Electrophoretic Transfer of Binding Reactions to Nylon Membrane 
 To prepare for transfer of the binding reaction to the nylon membrane, the 
membrane and transfer sponges were soaked in 0.5X nuclease free TBE for at least 10 
minutes.  The gel was removed from the cast, placed on the membrane, and sandwiched 
between sponges. The electrophoretic transfer unit was assembled and filled with cooled 
(~10 °C) 0.5X TBE and set on ice. The transfer was run at 300 mA for 50 minutes.  
3.5.4. Crosslink Transferred RNA to membrane 
 When the transfer was complete, the membrane was placed in a clean container 
and crosslinked using the auto crosslink function for 45 seconds.  
3.5.5. Detect Biotin-labeled RNA by Chemiluminescence  
 20mL of blocking buffer was incubated on the membrane for 15 minutes and 
decanted. Conjugate/blocking buffer solution was added (1:300 dilution), incubated for 15 
minutes, and decanted. 20mL of 1X wash solution was added and decanted.  The 
membrane was then washed 4 more times, each time incubating for 5 minutes. The 
membrane was transferred to a new container, and 30mL of substrate equilibration buffer 
was added and incubated for 5 minutes.  Working solution was prepared by adding 6mL 
Luminol/Enhancer Solution to 6mL Stable Peroxide Solution. The membrane was 
removed from the Substrate Equilibration Buffer, and placed on clean plastic wrap.  The 
working solution was poured on top on membrane to cover the entire surface. The 
membrane was incubated for 5 minutes and was removed, blotted, and wrapped in clean, 
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dry plastic wrap. The membrane was then exposed to a film cassette for 3 minutes in a 
dark room and placed in the Kodak develop machine.   
3.6. Protein-RNA Pulldown 
3.6.1. RNA Isolation 
 Using the Qiagen RNeasy® kit, RNA was isolated from P. gingivalis W83, and 
then treated with DNA-free™ kit (Ambion). RNA was electrophoresed on an agarose gel 
to test for degradation. 
3.6.2. Protein-RNA Pulldown using His-Tag on Dynabeads  
 10 µg of P. gingivalis W83 RNA that was isolated and treated with DNase was 
then added to 25 µg purified RBP, HUα, and HUβ. The RNA-protein mixture was 
incubated for 1hr at 4°C on a rotator. The mixture was then applied to 50 µL of cobalt 
Dynabeads. The pulldown was performed according to Dynabead (Invitrogen) protocol 
using nuclease free buffers (Fig 12).  
P. gingivalis W83 RNA was added to purified RBP, HUα, and HUβ and let 
incubate. The mixture was then applied to 50µL of cobalt Dynabeads and incubated. The 
tube was placed on a magnet for 2 min, and the supernatant was discarded. The beads 
were washed 4 times with binding buffer by placing the tube on the magnet for 2 min and 
discarding supernatant. The beads were thoroughly resuspended between each wash step. 
His-elution buffer was added to the beads and incubated on a rotator. The tube was then 
placed on the magnet for 2 min and the supernatant was transferred to a new clean tube. 
The elution was then treated with protease and used in RNA cleanup for RNA library 
generation and sequencing. 
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Figure 12: Schematic representation of Protein-RNA Pulldown using Dynabead. 
(Modified from Novex by Life Technologies) 
 
 
3.6.3. Protein-RNA pulldown using Halo-Tag 
To equilibrate the Halo link resin, it was mixed up and 1mL per 250mL original 
culture was added to a clean falcon tube. 20 mL of nuclease free purification buffer was 
added to the resin and spun at 2,000 RPM for 2 minutes. The buffer was removed by 
pipetting and repeated 2 more times.  
The cell lysate was applied to the resin and incubated at room temperature for 45 
minutes on a rocker. 60 µg RNA was added to each of the resin-tagged proteins and 
incubated at 4°C for 1 hour.  The resin-tagged protein was then washed with 20mL RNase 
free pulldown buffer that contained 3.25mM Sodium phosphate and 70mM NaCl, pH 7.4, 
and centrifuged at 2,000 RPM for 2 minutes. The wash was repeated 2 more times. 3mL 
was left in the tube after the final wash. 100µL TEV mix was added to each sample and 
incubated overnight at 4°C (Fig. 13).  
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Figure 13: Schematic representation of the Protein-RNA Pulldown using HaloTag 
isolation. Halotagged protein covalently binds to resin allowing stringent washes to wash 
away residual P. gingivalis RNA. TEV protease cleaves between the protein and Halotag 
to release the protein-RNA complex.  
 
 
3.7. Protease Treatment 
 90µL of protein-RNA supernatant from the pulldown was treated with protease 
from Streptomyces griseus (Sigma, P8811). 4.5µL of 20mg/mL protease stock solution, 
4.5µL 10% SDS, and 1.8 µL of 0.5M EDTA was added to the protein-RNA elution and 
incubated at 50°C for 1 hour.  
3.7.1 RNA cleanup 
 The Qiagen RNeasy® kit was used to isolate the RNA by following the protocol 
for RNA cleanup. Samples were saved at -20°C. 
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3.7.2. RNA Library Generation 
 SMARTer® Stranded RNA-Seq Kit (Clontech® Laboratories) was used according 
to protocol to synthesize cDNA, purify cDNA, amplify RNA-Seq library using PCR, and 
purify the RNA-Seq library (Fig 14).  
 
Figure 14: Schematic representation of SMARTer® Stranded RNA-Seq Library 
generation. (Clontech Laboratories protocol: 
http://www.clontech.com/US/Products/cDNA_Synthesis_and_Library_Construction/Next
_Gen_Sequencing_Kits/Strand-Specific_RNA_Seq_Illumina)  
 
The library generated was then sent to the sequencing center (VCU Sanger Hall) to 
be validated using the bioanalyzer. High throughput sequence results were then gathered 
and analyzed using statistical analysis. Fold change was used to compare the reads from 
RBP with HU proteins. 
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CHAPTER 4: RESULTS 
 
4.1. Creating recombinant DNA  
 The first aim is to test the interaction of candidate proteins: RBP (PG0565), HUβ 
(PG0121) and HUα (PG1258) with RNA. In order to examine the binding of candidate 
proteins with RNA, we prepared recombinant proteins. We used PCR SuperMix 
(Invitrogen) to amplify the target gene sequences. Gel electrophoresis was used to confirm 
the size of the fragment (Fig. 15). As expected, the size of the gene PG0565 is 
approximately 300 bp; this is what we expected so we could then move on to cloning 
PG0565.     
  
Figure 15: Gel Electrophoresis of the PCR amplification of PG0565. Lane 1: Ladder, 
Lane 2: PCR product 
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4.1.1. Cloning and transformation 
 To clone the genes into a plasmid, vector pCR2.1 was used. Genes PG0565, 
PG0121, and PG1258 were cloned into pCR2.1-TOPO vector using TA cloning kit. After 
ligation of the vector and inserts, the recombinant plasmids were transformed into 
Invitrogen One Shot TOP10 cells using heat shock method. The transformations were 
plated using IPTG and X-gal to select for plasmid with insertion of the genes. White 
colonies were cultured overnight and plasmids were purified using Q1prep Sin Miniprep 
Kit (Qiagen). Plasmids were digested with EcoRI in order to confirm the insertion of 
desired gene (Fig. 16). The screening for insert using restriction enzyme EcoRI showed 
that PG1258 is approximately 300 bp and the vector pCR2.1 is approximately 3.9kb as 
expected. We could then move on to insert the gene into pET-30a for His-tag protein 
expression. 
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Figure 16: Gel Electrophoresis image of EcoRI digestion of pCR2.1-PG1258. Lane 1: 
ladder, Lane 2: Recombinant plasmid digested with EcoRI 
 
 To produce a His-tagged recombinant protein, the genes PG0565, PG0121, and 
PG1258 needed to be cloned into vector pET-30a. The genes were thus digested out of 
pCR2.1 using XhoI and NcoI. The plasmid pET-30a was also digested with the same 
restriction enzymes for sticky end ligation (Fig17). Plasmid pET-30a digested with NcoI 
and XhoI showed pET-30a to be approximately 5.4kb. The results of the pCR2.1-PG0565 
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digested with NcoI and XhoI show that pCR2.1 is approximately 3.9kb and gene PG0565 
is approximately 300bp. The genes could then be ligated with vector pET-30a. 
 
Figure 17: Gel electrophoresis of NcoI and XhoI digested plasmids. Lane 1: Ladder. 
Lane 2: pET-30a digested with NcoI and XhoI. Lane 3: pCR2.1-PG0565 digested with 
NcoI and XhoI 
 
 To amplify inserts PG0565, PG0121, and PG1258, the gene inserts and pET-30a 
were ligated using T4 DNA Ligase and transformed into α-Select Silver E. coli (Bioline). 
To insure insert in pET-30a, the transformations were grown on kanamycin LB plates and 
colonies were cultured overnight in 20mL of LB media. The recombinant pET-30a 
plasmids were purified using the Q1prep Spin Miniprep Kit. In order to verify insertion of 
appropriate genes, the plasmids were digested with restriction enzymes NcoI and XhoI and 
the digestions were run on agarose gel (Fig 18). As shown in Fig. 18, pET-30a is 
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approximately 5.4kb and PG0121 is approximately 300bp. In Fig. 18, the results show the 
digestion of pET-30a is approximately 5.4kb and PG1258 is approximately 300bp. The 
recombinant plasmids were validated and we could then move on to transform the 
recombinant plasmids into BL21 competent E. coli for expression of recombinant 
proteins.  
 
Figure 18: Gel Electrophoresis of XhoI and NcoI digestion of pET-30a-PG0121 and 
pET-30a-PG1258 to verify colonies with insert PG0121 and PG1258 into pET30-a. 
Lane 1: Ladder, Lane 2: Recombinant plasmid pET-30a-PG0121 digested with XhoI and 
NcoI, Lane 3: Recombinant plasmid pET-30a-PG1258 digested with XhoI and NcoI.  
 
 After validating gene insertions into pET-30a, the plasmids were then transformed 
into BL21 E. coli. We used BL21 chemically competent E. coli cells because they are 
suitable for transformation and protein expression. The BL21 strains were used to express 
   44 
and purify recombinant proteins as described in “Materials and Methods”.  The elutions 
from the His-tag purification on Ni-resin were run on denaturing protein gels to show 
protein expression and purity (Fig 19). His-tag purification of RBP, HUβ, and HUα was 
analyzed using 12% Bis-Tris gel showing each protein is approximately 16kD. RBP 
elution showed some background, while HUβ and HUα are pure. These samples were 
then used to continue to electrophoretic mobility shift assays. 
  
Figure 19: SDS-PAGE analysis of his-tag purified RBP, HUβ  and HUα . 12% Bis-Tris 
gel was used for the analysis. (A.) Lane 1: Ladder, Lane 2:RBP. (B.) Lane 1: ladder, Lane 
2: HUβ, Lane 3: HUα. 
 
4.2. Electrophoretic Mobility Shift Assay   
Electrophoretic mobility shift assay (EMSA) technique was used to show the 
ability of the proteins to bind RNA in vitro. The purified proteins were dialyzed in RNase 
free binding buffer so that they could be used in reactions containing RNA. EMSA was 
performed as described in “Materials and Methods”. The first reaction as listed in Table 5 
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shows the interaction of RBP, HUβ and HUα with control IRE RNA and the effect of 
competitor unlabeled RNA on protein-RNA binding. In Figure 20, the control reaction 
shows the IRE RNA probe without protein, with Cytosolic liver extract containing 
aconitase binding IRE, and with Cytosolic liver extract and competitor RNA. With no 
protein added, there was no shift in the probe. There was a shift in the labeled RNA when 
liver extract was added. The amount of labeled RNA shifted was decreased with addition 
of unlabeled RNA showing binding specificity between the Cytosolic aconitase and IRE 
RNA (Fig. 20). This provided a comparison for future binding reactions.  
 
Figure 20: EMSA Control reactions using Liver Extract, biotinylated IRE RNA and 
unlabeled IRE RNA. Lane 1: Contains labeled IRE RNA, Lane 2: Contains cytosolic 
liver extract and labeled IRE RNA, Lane 3: Contains cytosolic liver extract, unlabeled IRE 
RNA (competitor RNA) and labeled IRE RNA 
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The control reactions provided a comparison for reactions with RBP, HUβ, HUα 
and Lysozyme. Figure 21 shows the results from binding reactions listed in Table 5. There 
was no shift visible in the reactions with RBP. There was a shift in the labeled IRE RNA 
probe in the reaction with HUβ with a decrease in shift with the addition of competitor 
unlabeled RNA. The reaction with HUα showed a shift in the labeled IRE RNA probe 
with a decrease in shift of IRE RNA with the addition of competitor unlabeled IRE RNA 
probe meaning that the binding is specific.  Lysozyme served as a negative control. There 
was a shift seen in the lysozyme binding reactions, but was not decreased with the 
addition of competitor RNA meaning that the binding is non-specific.  
 
 
Figure 21: EMSA reaction using RBP, HUβ , HUα  and Lysozyme with labeled IRE 
RNA probe. Panel a.) RBP: lane 1 contains RBP and labeled IRE RNA, lane 2 contains 
RBP, unlabeled IRE RNA, and labeled IRE RNA. Panel b.) HUβ: lane 1 contains HUβ 
and labeled IRE RNA, lane 2 contains HUβ, unlabeled IRE RNA, and labeled IRE RNA. 
Panel c.) HUα: lane 1 contains HUα and labeled IRE RNA, lane 2 contains HUα, 
unlabeled IRE RNA, and labeled IRE RNA. Panel d.) Lysozyme: lane 1 contains 
lysozyme and labeled IRE RNA, lane 2 contains lysozyme, unlabeled IRE RNA, and 
labeled IRE RNA.  
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4.2.1. EMSA dose dependent reactions 
In order to further investigate the RBP interaction with RNA, we used increasing 
amounts of RBP in the reaction with IRE RNA (Table 6) to observe the change in shift as 
the protein concentration increased. Also, the unlabeled IRE RNA was used as the 
competitor IRE RNA to compare for specificity.  The results (Fig. 22) show an increase in 
probe shift (in the red box) as the protein concentration increases. Also, there is an overall 
decrease in shift in the reactions containing competitor RNA.  
 
Figure 22: EMSA dose dependent reaction using RBP with labeled and competitor 
IRE RNA probe Lanes 1: No protein + probe, Lane 2: Cytosolic liver extract + probe, 
Lane 3: Cytosolic liver extract + probe + unlabeled IRE RNA, Lane 4: 0.28 µg RBP + 
probe, Lane 5: 0.7 µg RBP + probe, Lane 6: 1.4 µg RBP + probe, Lane 7: 2.8 µg RBP + 
probe, Lane 8: 4.2 µg RBP + probe, Lane 9: 0.28 µg RBP + probe + unlabeled IRE RNA, 
Lane 10: 0.7 µg RBP + probe + unlabeled IRE RNA, Lane 11: 1.4 µg RBP + probe + 
unlabeled IRE RNA, Lane 12: 2.8 µg RBP + probe + unlabeled IRE RNA, Lane 13: 4.2 
µg RBP + probe + unlabeled IRE RNA 
 
 
 
   48 
4.2.2. Synthesized RNA Motifs  
In order to further investigate the RBP interaction with RNA, we synthesized two 
biotinylated RNA probes based on the common RNA motifs that bind to proteins. Because 
we had many motifs on this one piece of RNA, the probe is named “long” and a shorter 
probe named “short”. The EMSA dose dependent reaction was performed as described in 
“Materials and Methods” with increasing amounts of RBP in each reaction beginning with 
no protein and increasing up to 4.2 µg. One reaction used the long RNA probe and the 
next used the short RNA probe with RBP. The results in Figure 23 show the increasing 
amount of RBP added to the reaction caused an increase in shift of the labeled RNA 
probe. There is no shift observed in the reaction containing lysozyme and long RNA probe 
 
Figure 23: EMSA dose dependent reaction with increasing concentration of RBP 
protein incubated with “long” RNA probe. Black box designates the shift in long probe. 
Lysozyme was used as the negative control. 
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The results of the dose dependent reaction with short probe are shown in Figure 
24. There was no shift in short RNA probes with addition of RBP. The increasing amount of 
RBP added to the reaction did not have an effect on the shift of the short-labeled RNA 
probe. There is no shift observed in the reaction containing lysozyme and short RNA probe. 
 
 
Figure 24: EMSA dose dependent reaction with increasing concentration of RBP 
protein incubated with “short” RNA probe. No shift in short probe. Lysozyme was 
used as negative control. 
 
4.3. Protein-RNA Pulldown 
4.3.1 RBP Purification 
 The next aim was to isolate the protein-RNA complexes and sequence the P. 
gingivalis W83 RNAs bound to candidate RNA-binding proteins. This was accomplished 
using protein-RNA pulldowns to isolate RNA by its interaction with protein. In order to 
ensure the candidate protein would bind properly to P. gingivalis RNA, the protein needed 
to be quite pure and expressed well. The RBP his-tag purification method using Ni-resin 
(Fig. 25) showed high expression, but also shows high amounts of RBP in flow-through, 
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yielded elution with high amounts of unwanted proteins, and low concentrations of 
recombinant protein in elutions. An alternate method of purification needed to be used in 
order to obtain more pure samples of RBP.  
 
Figure 25: SDS-PAGE analysis of his-tag purification of RBP under denaturing 
conditions. RBP is approximately 16kD. 12% Bis-Tris gel was used for the analysis. 
Lane 1: Ladder, Lane 2: Flow-through, Lane 3: RBP purification elution, Lane 4: RBP 
purification elution   
 
 In order to purify RBP adequately, a size exclusion column was used. This method 
provided very pure samples of RBP with higher concentrations than the Ni-resin method 
(Fig. 26). RBP purified without background noise. RBP is approximately 15kD. The RBP 
samples from the size exclusion were then dialyzed in RNase free binding buffer in 
preparation for the protein-RNA Pulldown using Dynabeads (Novex by Life 
Technologies).  
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Figure 26: SDS-PAGE analysis of RBP purification using size exclusion. 12% Bis-Tris 
gel was used for the analysis. Two elutions of RBP isolated using size exclusion shown 
with ladder.  
 
4.3.2. RNA Isolation from P. gingivalis W83 
 In order to investigate candidate proteins’ ability to bind RNA in P. gingivalis, 
RNA was isolated from P. gingivalis W83 using the Qiagen RNA isolation kit. The 
isolated RNA was run on RNase free agarose gel to determine the quality of the RNA. Gel 
electrophoresis of RNA showing two bands representing the non-degraded, intact 
ribosomal RNA (Fig. 27). The RNA was treated with DNase and incubated with candidate 
proteins to allow for protein-RNA complexes to form.  
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Figure 27: Gel Electrophoresis of isolated P. gingivalis W83 RNA. Lane 1: RNA 
isolation prep 1, Lane 2: RNA isolation prep 2.  
 
4.3.3. Dynabead Pulldown 
 To allow for protein-RNA complexes to form, the size exclusion purified RBP, 
and Ni-resin purified HUβ and HUα were thoroughly dialyzed in RNase free binding 
buffer. The proteins were then incubated with isolated P. gingivalis W83 RNA to allow 
for interaction. The pulldown was performed as described in “Materials and Methods” to 
isolate P. gingivalis RNA based on its interaction with the candidate proteins.  Samples 
from each pulldown were run on denaturing SDS-PAGE to confirm protein was present in 
elution (Fig. 28). Based on the SDS-PAGE shown in Figure 28, RBP purified using size 
exclusion failed to bind to Dynabeads. The HUβ and HUα bound to Dynabeads and could 
be recovered in elution. I could proceed with the pulldown of HUβ and HUα, but an 
alternative isolation technique for RBP needed to be used.  
   53 
 
Figure 28: SDS-PAGE analysis of aliquots from Protein-RNA Pulldown. 12% Bis-
Tris gel was used for the analysis. Lane 1: Ladder, Lane 2: Aliquot from RBP(size 
exclusion purified) + RNA Pulldown, Lane 3: Aliquot from HUβ + RNA Pulldown, Lane 
4: Aliquot from HUα + RNA Pulldown 
 
4.4. Generation of genetic construct coding for RBP with C-terminal His-tag 
 In attempt to improve RBP his-tag binding to Ni resin and cobalt Dynabead, we 
generated new recombinant DNA with the his-tag on the C-terminus. Using the primer 
listed in “Materials and Methods”, PCR was performed to amplify gene PG0565. We used 
gel electrophoresis to confirm the fragment size to be about 300bp (Fig. 29). We could 
then move on to clone the gene insert into vector pCR2.1.  
   54 
 
Figure 29: Gel Electrophoresis of the PCR product for cloning PG0565 for C-
terminal His-tag. Lane 1: Ladder, Lane 2: PCR product 
 
In order to clone the PCR product, pCR2.1 vector was used and transformed into 
OneShot Top10 competent E. coli (Invitrogen). The transformation was plated using IPTG 
and X-gal to screen for plasmid with insertion of the genes. White colonies were cultured 
overnight and plasmids were purified using Q1prep Sin Miniprep Kit (Qiagen). Plasmids 
were digested with EcoRI in order to confirm the insertion of desired gene (Fig. 30). As 
expected, PG0565 is approximately 300bp and pCR2.1 is approximately 3.9kb. The insert 
could then be digested out to insert into pET-30a. 
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Figure 30: Gel Electrophoresis to screen colonies for insertion of PG0565 using 
restriction enzyme EcoRI. Lane 1: Ladder, Lane 2: Recombinant plasmid pCR2.1-RBP 
digested with EcoRI.  
 
To produce the C-terminal his-tagged recombinant protein RBP, the gene PG0565 
needed to be cloned into vector pET-30a. The gene was digested out of pCR2.1 using 
XhoI and NdeI. As expected, PG0565 is approximately 300bp and pCR2.1 is 
approximately 3.9kb. The plasmid pET-30a (approximately 5.4kb) was also digested with 
the same restriction enzymes and sticky end ligation could be performed (Fig. 31).  
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Figure 31: Gel Electrophoresis of pCR2.1-PG0565 and pET-30a digested with XhoI 
and NdeI. Lane 1: Ladder, Lane 2: pCR2.1-PG0565 digested with XhoI and NdeI, Lane 3: 
pET-30a digested with XhoI and NdeI. 
 
PG0565 gene and vector pET-30a were ligated using T4 DNA Ligase and 
transformed into e α-Select Silver E. coli (Bioline). To insure insertion of PG0565 in pET-
30a, the transformations were screened on kanamycin LB plates and colonies were 
cultured overnight in 20mL of LB media. The pET-30a plasmids with insertion were 
purified using the Q1prep Spin Miniprep Kit. In order to verify insertion of appropriate 
gene, we digested the plasmid with restriction enzymes NcoI and NdeI and ran the 
digestion on agarose gel (Fig. 32). As expected, vector pET-30a is approximately 5.4kb 
and PG0565 is approximately 300bp. The plasmid appeared to be pure and we could move 
on to expression of the recombinant RBP. 
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Figure 32: Gel Electrophoresis of pET-30a-PG0565 digested with XhoI and NdeI to 
confirm content of the plasmid. Lane 1: Ladder, Lane 2: Recombinant plasmid pET-30a-
PG0565 digested with XhoI and NdeI.  
 
After validating gene insertion into pET-30a, the plasmid was then transformed 
into BL21 E. coli. We used BL21 chemically competent E. coli cells because they are 
suitable for transformation and protein expression. The BL21 strain was used to express 
and purify recombinant proteins as described in “Materials and Methods”.  The elutions 
from the his-tag purification on Ni-resin were run on denaturing protein gels to show 
protein expression and purity (Fig. 33). Flow-through shows a large amount of RBP 
coming out in solution. His-tag RBP elution 1 shows two bands of RBP. The elution 2 
shows a pure band of RBP that we used to continue to the pulldown.  
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Figure 33: SDS-PAGE analysis of RBP purified with C-terminal his-tag 
chromatography. 12% Bis-Tris gel was used for the analysis. Lane 1: Flow-through, 
Lane 2: His-tag RBP elution 1, Lane 3: His-tag RBP elution 2. 
 
4.5. Repurification and concentration of RBP, HUβ  and HUα   
 In order to concentrate the his-tag proteins that could bind efficiently to Dynabeads 
during pulldown, the proteins were repurified on the Dynabeads according to protocol. 
Samples form the protein elutions were run on SDS-PAGE to confirm purity and 
concentration (Fig. 34). The results showed pure bands of adequate concentration to 
continue to the protein-RNA pulldown on dynabeads. The elutions from the repurification 
showed one band representing the pure recombinant proteins. RBP with His-tag on the C-
terminus is 12kDa due to a shorter linker sequence than the C-terminal His-tag. HUβ and 
HUα are both about 16kDa. The candidate proteins were of good purity and could then be 
used to perform His-tag protein-RNA pulldown on Dynabeads (Novex by Life 
Technologies).  
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Figure 34: SDS-PAGE analysis of re-purification using Dynabeads. 12% Bis-Tris gel 
was used for the analysis. Lane 1: Re-purified RBP, Lane 2: Re-purified HUβ, Lane 3: Re-
purified HUα 
 
4.6. His-Tag RNA-Protein Pulldown 
 In order to isolate P. gingivalis RNA based on protein binding, the candidate 
RNA-binding proteins were thoroughly dialyzed in RNase free binding buffer. P. 
gingivalis RNA that was isolated and treated with DNase was then added to the re-purified 
RBP, HUβ and HUα. The RNA-protein mixture was incubated on a rotator to allow 
binding. The mixture was then applied to Dynabeads. The pulldown was performed 
according to Dynabead protocol (Invitrogen) using nuclease free buffers as listed in 
“Materials and Methods”. Samples from the pulldown were run on SDS-PAGE denaturing 
gel to confirm presence of protein in elution (Fig. 35).  As seen in the SDS-PAGE 
analysis, each protein was recovered from the protein-RNA pulldown. From here we 
could move on to treating the complexes with protease to release the RNA from the 
protein-RNA complex for RNA-seq.  
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Figure 35: SDS-PAGE analysis of protein-RNA pulldown using his-tag on 
dynabeads. 12% Bis-Tris gel was used for the analysis. Lane 1: Ladder, Lane 2: Aliquot 
from Pulldown of re-purified RBP + P. gingivalis W83 RNA, Lane 3: Aliquot from 
Pulldown of re-purified HUβ + P. gingivalis W83 RNA, Lane 4: Aliquot from Pulldown 
of re-purified HUα + P. gingivalis W83 RNA 
 
4.6.1. Protein-RNA pulldown using Halo-Tag 
In order to perform another pulldown assay with the candidate proteins, the genes 
were inserted into pCF20K HaloTag vector. HaloTag purification was used to isolated P. 
gingivalis RNA based on it’s binding to the candidate protein. The pFC20K HaloTag 
plasmids with PG0565, PG0121, and PG1258 gene inserts were transformed into BL21 
and expressed using IPTG. The induced cell cultures were lysed, and the lysate was then 
applied to the resin and incubated to allow for the HaloTag to bind covalently to the resin. 
P. gingivalis RNA was added to each of the resin-bound proteins and incubated to allow 
protein and RNA to interact. The resin-bound proteins were washed thoroughly with 
RNase free pulldown buffer.  TEV mix was added to each sample to cleave the protein 
from the resin in order to elute the protein. Samples from the pulldown were run on SDS-
PAGE denaturing gel to confirm presence of protein in elution (Fig. 36). As seen in the 
SDS-PAGE analysis, each protein was recovered from the protein-RNA pulldown. From 
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here we could move on to treating the complexes with protease to release the RNA from 
the protein-RNA complex for RNA-seq.  
 
Figure 36: SDS-PAGE analysis of HaloTag proteins from pulldown. 12% Bis-Tris gel 
was used for the analysis. Lane 1: Ladder, Lane 2: Aliquot from halo-tag Pulldown of 
RBP + P. gingivalis W83 RNA, Lane 3: Aliquot from halo-tag Pulldown of HUβ + P. 
gingivalis W83 RNA, Lane 4: Aliquot from halo-tag Pulldown of HUα + P. gingivalis 
W83 RNA 
 
4.7. RNA Library Generation 
 P. gingivalis RNA was released from bound protein by treatment with protease 
from Streptomyces griseus (Sigma, P8811). The RNA was isolated as described in the 
“Materials and Methods” and used to generate an RNA library. Using reverse 
transcription, cDNA was generated and PCR was used to amplified the cDNA strands. 
The library generated was then sent to the sequencing center (VCU Sanger Hall) to be 
validated and sequenced.  
4.7.1. Validation of RNA-Seq Library using the BioAnalyzer  
 Before continuing to high throughput sequencing, the quality of the RNA was 
analyzed using the bioanalyzer. The peaks represent the cDNA fragment lengths (bp).  
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A distinct peak spanning 150-1,000 bp, peaked at about 300 bp for the RNA sample yields 
product greater than 7.5 nM RNA-seq Library. The accuracy of the sequencing is optimal 
for strands under 1,000bp. The results for the samples (Fig. 37-42) showed that the cDNA 
was suitable for further processing. 
                        
Figure 37: Electropherogram results from bioanalyzer of P. gingivalis RNA from 
RBP-RNA His-Tag pulldown 
 
                       
Figure 38: Electropherogram results from bioanalyzer of P. gingivalis RNA from 
HUβ-RNA His-Tag pulldown 
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Figure 39: Electropherogram results from bioanalyzer of P. gingivalis RNA from 
HUα-RNA His-Tag pulldown 
 
 
Figure 40: Electropherogram results from bioanalyzer of P. gingivalis RNA from 
RBP-RNA HaloTag pulldown 
 
 
Figure 41: Electropherogram results from bioanalyzer of P. gingivalis RNA from 
HUβ-RNA HaloTag pulldown 
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Figure 42: Electropherogram results from bioanalyzer of P. gingivalis RNA from 
HUα-RNA HaloTag pulldown 
 
4.7.2. High throughput sequencing of RNA libraries 
The samples were then sequenced using Rapid flow cell (VCU Sanger Hall). From 
the high throughput sequencing results, we were able to align the DNA fragments along 
the P. gingivalis genome (Fig. 43). Across the whole P. gingivalis genome showed areas 
of high copy numbers. There was not much variation between RBP and HU proteins. Also 
the areas of highest copy numbers were genes encoding for ribosomal RNA. Statistical 
analysis was then used to further examine the difference in genome locus binding sites 
between RBP, HUβ and HUα. 
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Figure 43: High throughput sequencing reads aligned with P. gingivalis genome 
 
 
4.7.3. Statistical Analysis of RNA-sequencing results 
 
Statistical analysis allowed us to compare the reads per kilo base per million 
mapped reads (RPKM) from His-tagged RBP and His-tagged HUβ (Table 8), as well as 
Halotag RBP and His-tag HUβ (Table 9). The fold change gives us a ratio that allows us 
to see an increase in binding of RBP compared to the HU protein. From results not shown, 
the area of highest copy numbers among RBP, HUβ and HUα are16S and 23S ribosomal 
RNA. This non-specific binding was disregarded and we examined other gene loci to 
investigate possible significant protein binding sites along the P. gingivalis genome.  
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Table 8: P. gingivalis genes most significantly bound to His-tagged RBP compared to 
His-tagged HUβ  determined using RNA-seq analysis. A. Locus ID based on Los 
Alamos, B. Definition based on BROP genome viewer, C. Reads per kilo base per million 
mapped reads (RPKM)-His-tag RBP, D. Reads per kilo base per million mapped reads 
(RPKM)-His-tag HUβ, E. Ratio of the number of reads that align at each position from 
RBP to the reads from HUβ.  
 
Locus 
ID Definition 
RPKM 
RBP 
His  
RPKM 
HUβ  
His  
Experiment- 
Fold Change  
RBP His/HUB 
His 
A B C D E 
PG1828 Cation efflux system protein 71.29 5.18 13.77 
PG1085 
probable peptidyl-prolyl cis-trans 
isomerase 104.19 15.94 6.54 
PG1421 hypothetical protein 51.80 9.03 5.74 
PG0607 
indolepyruvate ferredoxin 
oxidoreductase alpha subunit 43.57 9.72 4.48 
PG2213 
oxidoreductase, short chain 
dehydrogenase-reductase family 34.57 8.44 4.10 
rpsO short-chain dehydrogenase 65.62 18.78 3.49 
PG0555 hypothetical protein 38.20 11.05 3.46 
PG0195 
ABC transporter protein, ATP-
binding protein 269.56 91.41 2.95 
PG1196 prolyl tripeptidyl peptidase (Ptp-A) 4.14 0 0 
 
 
 
 
 
 
 
 
 
 
   67 
Table 9: P. gingivalis genes most significantly bound to Halotag RBP compared to 
His-tagged HUβ  determined using RNA-seq analysis. A. Locus ID based on Los 
Alamos, B. Definition based on BROP genome viewer, C. Reads per kilo base per million 
mapped reads (RPKM)-Halotag RBP, D. Reads per kilo base per million mapped reads 
(RPKM)-His-tag HUβ, E. Ratio of the number of reads that align at each position from 
RBP to the reads from HUβ. 
 
Locus 
ID  Definition 
RPKM 
RBP 
Halo  
RPKM 
HUβ  
His  
Experiment - 
Fold Change 
RBP Halo/HUB 
His 
A B C D E 
PG1828 Cation efflux system protein 638.87 5.18 123.42 
PG1196 prolyl tripeptidyl peptidase (Ptp-A) 4.02 0 0 
PG1574 hypothetical protein 4.02 0 0 
PG1206 uridine phosphorylase 4.15 0 0 
PG1655 
probable tonB-linked outer 
membrane receptor 4.39 0 0 
PG0822 Hypothetical protein 4.52 0 0 
PG1445 
methylmalonyl-CoA mutase alpha 
subunit 4.70 0 0 
PG1223 rod shape-determining protein 6.02 0 0 
PG1722 hemagglutinin hagB 6.02 0 0 
PG1373 conserved hypothetical protein 8.90 0 0 
PG1866 hypothetical protein 14.63 0 0 
greA 
transcription elongation factor 
(GreA) (trancript cleavage factor) 9.78 0.94 10.45 
coaD 
phosphopantetheine 
adenylyltransferase 9.31 0.95 9.75 
PG1451 
ABC transporter protein, ATP-
binding protein 10.54 1.08 9.75 
PG0507 conserved hypothetical protein 11.03 1.13 9.75 
PG0408 
molybdopterin synthase 
sulphurylase 9.20 1.24 7.43 
PG1980 hypothetical protein 16.17 1.29 12.54 
PG0007 ISPg5 transposase 17.39 1.39 12.54 
PG0161 
cell surface protein fragment 
(fimbrillin-related) 14.33 1.47 9.75 
PG1978 hypothetical protein 22.48 2.51 8.95 
PG1449 
RNA polymerase sigma factor, 
ECF subfamily (sigma-70) 16.24 2.59 6.27 
PG1203 glucose-6-phosphate isomerase 40.96 3.15 13.00 
menA 1,4-dihydroxy-2-naphthoate 32.52 4.47 7.27 
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octaprenyltransferase (DHNA-
octaprenyltransferase) 
 
PG1358 
tonB-dependent receptor HmuR (or 
HemR) 25.71 4.53 5.67 
PG0423 folylpolyglutamate synthase 56.88 4.54 12.54 
PG1186 hypothetical protein 30.10 4.57 6.59 
PG0650 response regulator 29.60 4.59 6.44 
PG0115 phosphoglycerate mutase 39.27 5.03 7.80 
PG0119 
Mg2+ transport protein MgtE (CBS 
domain) 30.32 5.05 6.01 
PG1276 hypothetical protein 47.86 6.09 7.86 
PG0173 hypothetical protein 122.35 6.23 19.64 
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CHAPTER 5: DISCUSSION 
 
Gene regulation is vital for bacterial adaptation to dynamic environments. 
Riboregulation is becoming more widely accepted as a prominent form of gene regulation 
in bacterial organisms. The ability of P. gingivalis to survive in the challenging 
environment of the oral cavity leads us to believe that it also uses riboregulation, 
specifically RNA-binding proteins, to rapidly adapt and regulate its gene expression in 
response to stress. However as of yet, no RNA-binding protein has been reported to be 
present in P. gingivalis. 
Using bioinformatics, my lab has identified three proteins of interest: RBP 
(PG0565, PG0627), HUβ (PG0121) and HUα (PG1258) in P. gingivalis that were further 
investigated as putative RNA-binding proteins. BROP shows that RBP shares sequence 
homology with putative RNA-binding proteins of other pathogens. RBP is a strong RNA-
binding protein candidate to investigate because unpublished data in the Lewis lab shows 
that the knock out PG0565 mutant cannot survive with eukaryotic cells. If RBP’s target 
RNA can be identified, it may aid in the development of alternate treatment for chronic 
periodontitis. 
HUβ and HUα were previously selected as controls due to the likelihood that these 
proteins also bind RNA in P. gingivalis. HUβ and HUα are among the P. gingivalis 
proteins annotated by BROP as histone-like DNA-binding proteins that are related to HU. 
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The gene PG0121 encodes a functional homologue for E. coli HU and shares a 76.7% 
sequence similarity to the E. coli HUβ (Pearson & Lipman, 1988; Priyadarshini et al., 
2013). In E. coli, HU binds to single stranded DNA, and also has been shown to bind 
mRNA (Balandina et al., 2001). The ability of P. gingivalis HUβ to bind to RNA has not 
been tested (Tjokro et al., 2014), but it is hypothesized that HUβ binds mRNA to increase 
expression of the K-antigen capsule.   
I hypothesized that RBP, HUβ and HUα bind RNA in P. gingivalis. The first aim 
was to show that RBP, HUβ, and HUα bind to RNA. EMSA was used to show interactions 
between RNA and protein, visible by a shift in the labeled RNA. The second aim was to 
isolate P. gingivalis RNA-protein complexes and sequence the P. gingivalis RNA.  His-
tag and halotag pulldowns were used to isolate the complexes and sequence the RNA.  
In order to test the binding of RBP, HUβ, and HUα with RNA, it was important to 
obtain pure samples of RBP, HUβ and HUα with low background of other proteins. The 
purification of RBP using the His-tag on the C-terminus was not effective.  RBP was well 
expressed but was coming out in the flow through (Fig. 25). This could be due to the 
secondary structure of the protein hiding the His-tag making it inaccessible to the Ni-resin. 
Also, the elutions contained background of other proteins because we could not wash as 
stringently with IMD. We attempted to optimize the wash buffer IMD concentration and 
volume, but RBP came out in wash and still lacked purity.   
Size exclusion method was then used in attempt to further purify RBP. This 
method provided pure samples with no background and yielded adequate amounts of RBP 
needed for EMSA and the pulldowns (Fig. 26).   The HUβ and HUα his-tag proteins 
purified from the Ni-resin without issues and allowed us to move on to EMSA and the his-
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tag pulldown on the dynabeads.  As will be discussed later in further detail, RBP from the 
size exclusion purification was unable to be recovered from his-tag pulldowns (Fig. 28). 
RBP isolated from the size exclusion did not isolate the protein based on its ability to bind 
to Ni-resin.  Therefore, when the RBP was applied to the Dynabead, the His-tag of the 
protein was not adequately exposed and was unable to bind to the cobalt Dynabead. This 
was an issue because normally cobalt binds His-tag more efficiently than Ni-resin, but we 
still could not recover the RBP from the Dynabead. This led us to the generation of a 
genetic construct coding for RBP with an C-terminal his-tag. RBP with a C-terminal his-
tag purified more efficiently than the RBP with C-terminal his-tag (Fig. 33) and we were 
able to use pure RBP samples for both EMSA and his-tag pulldowns. The more successful 
purification of the construct with the His-tag on the C-terminal could be due to the protein 
secondary structure folding with C-terminus on the interior and the C-terminus on the 
exterior surface.  
EMSA was used to characterize the interaction of RBP, HUβ and HUα with IRE 
RNA and the interaction of RBP with synthesized RNA motifs. In binding reaction I 
(Table 5), the probe used was biotinylated IRE RNA. IRE RNA was incubated with RBP 
as the experimental protein, HUβ and HUα as controls, and lysozyme as the negative 
control. An unlabeled IRE RNA was used as a competitor RNA. The results (Fig. 21) 
showed that the RBP did not cause the IRE RNA to shift. HUβ and HUα bind IRE RNA, 
as well as the negative control, Lysozyme, indicating an interaction with the IRE RNA. 
The reactions containing unlabeled IRE RNA for HUβ and HUα showed a decrease in 
shifted probe with the addition of competitor RNA. This indicates that the binding of IRE 
RNA with HUβ and HUα is specific. Lysozyme shifts IRE RNA without much variability 
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in the presence of competitor RNA. This indicates that the binding is non-specific and the 
conditions were optimal for the binding of IRE RNA with Lysozyme.  
In order to further investigate the RBP interaction with IRE RNA, we gradually 
increased the amounts of RBP in binding reaction II (Table 6). The dose dependent 
reaction showed an increase in what seemed to be a shift, and a decrease in overall shift 
with the addition of the competitor RNA (Fig. 22). Upon a second look, the “shift” 
appeared to be similar to the control lane containing no protein (Fig. 22, Lane 1). The IRE 
RNA in lane 1 may be forming bulky motifs causing a shift without the addition of 
protein. Control lanes 2 and 3 show a shift leaving behind residual unbound RNA. This 
serves as a good mark for the baseline. The reactions containing RBP do shift the RNA 
from this baseline.   
The interaction of RBP with RNA needed to be further tested; so specific 
biotinylated RNA motifs were generated based on motifs commonly associated with 
protein-RNA binding (Chen & Varani, 2013; Kang et al., 2006; Blakeley et al., 2013; 
Keiler, 2012). The probes were named “long” and “short” based on their size. The long 
RNA probe contained more motifs, while the short RNA probe contained some of the 
same motifs.  
Binding reaction III (Table 7) used the long probe incubated with RBP in 
increasing amounts starting with no protein.  Lysozyme was used as the negative control. 
The results (Fig. 23) showed a shift in the probe by RBP indicating RBP binds RNA. 
Also, it should be noted that the baseline representing residual unbound RNA decreases as 
more RBP is added. In lane 1 of figure 23, there is a shift seen without RBP added. The 
shift above the black box is present in each lane of the reaction. This may be due to the 
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RNA forming secondary structures. In the attempt to alleviate this problem, the RNA was 
boiled to denature the RNA and then kept on ice through the duration of the experiment. 
Due to the nature of the experiment there was time spent with the RNA at room 
temperature, which may have allowed the RNA to reform its secondary structures.  
The next reaction, binding reaction IV (Table 7), used the short RNA probe with 
increasing amounts of RBP and lysozyme as the negative control. The results (Fig. 24) 
show no shift in the short probe as RBP increases. This information is helpful to us 
because it narrows down the possible motifs the protein binds. The results from both the 
long probe and short probe dose dependent reactions show that RBP binds to specific 
motifs or sequences of RNA.  
The second aim was to isolate P. gingivalis RNA-protein complexes and sequence 
the P. gingivalis RNA. In order to isolate RNA from the protein-RNA complex, it was 
important to obtain pure samples of RBP, HUβ and HUα with low background of other 
proteins. The purification of RBP using the His-tag on the C-terminus was not effective. 
Even though RBP was well expressed, a lot of the protein was coming out in the 
flowthrough. In addition, it was difficult to obtain pure elutions without heavy background 
of other proteins. After attempting to optimize the wash buffer IMD concentration and 
volume, RBP elutions were still not pure and RBP was coming out in wash and visible on 
SDS-PAGE analysis.   
The next attempt to obtain pure samples of RBP was the use of size exclusion 
purification. This method provided pure samples of RBP with no background and high 
concentrations (Fig. 26). The HUβ and HUα his-tag proteins purified from the Ni-resin 
without issues and provided pure samples for the his-tag pulldown on the dynabeads.   
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The results from the pulldown using size exclusion purified RBP (Fig. 28) show no 
RBP isolated. HUβ and HUα were able to be isolated from the dynabeads. There is some 
degradation of HUβ and HUα visible by SDS-PAGE analysis. The his-tag of RBP was not 
binding to the Ni-resin or the dynabeads as efficiently as HUβ and HUα. The 
conformation of RBP may fold in a way that makes the his-tag on the C-terminus 
inaccessible. In order to resolve this problem, we generated a genetic construct coding for 
RBP with a C-terminal His-tag.  
RBP with the C-terminal His-tag was more efficiently purified on Ni-resin (Fig. 
33). After purifying RBP, HUβ and HUα on the Ni-resin, the protein samples were then 
repurified on dynabeads to concentrate and optimize the pulldown (Fig. 34). Also, the 
purification on dynabeads provided a means to concentrate the samples since 700 µL were 
applied to the beads, and 50 µL were eluted. The samples from the repurification were 
then incubated with P. gingivalis RNA pretreated with DNase, and Dynabeads were used 
to isolate the protein-RNA complex. Aliquots from the pulldowns were run on SDS-
PAGE to allow us to analyze the isolation of at least the protein of the protein-RNA 
complex (Fig. 35). 
The use of the Halotag was initiated due to the difficulties purifying RBP with the 
C-terminal his-tag. RBP, HUβ and HUα were cloned into a Halotag vector for Halotag 
pulldowns. The Halotag isolation yielded more pure samples of RBP, HUβ and HUα. The 
nature of the Halotag allows stringent washes because it forms a covalent bond with the 
resin.  After the successful purification of RBP with the C-terminal his-tag, we still 
continued with the Halotag pulldown (Fig. 36) because it would serve as a biological 
replicate.  The Halotag pulldowns were analyzed on SDS-PAGE and showed we were 
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able to isolate RBP, HUβ and HUα. The elutions from both the his-tag and Halotag 
pulldowns were then used to generate RNA libraries.  
Treating the samples with protease degraded the protein to release the RNA from 
the complex. RNA cleanup was then used to obtain pure RNA samples to use for 
sequencing. The RNA sequencing kit (Clontech) uses less than nanogram amounts of 
RNA to generate cDNA and amplify cDNA by PCR. Before investing in sequencing, the 
samples were tested for quality using a bioanalyzer (Figures 37, 38, 39, 40, 41, & 42). 
This measured the base pairs of the cDNA fragments. Fragments under 1,000 bp were 
ideal to provide sequence information. Fragments from the HUβ Halotag pulldown were 
longer than 1,000 bp and did not provide useful data.  
The sequencing results allowed us to align the reads of the cDNA fragments with 
the P. gingivalis genome and to compare reads from RBP to HUβ and HU control 
pulldowns. The sequencing results showed high copy numbers of reads across the P. 
gingivalis genome for both the experimental protein and controls (Fig. 43).  One possible 
explanation for this could be that the RNA in the protein-RNA complex is a long strand 
containing many genes. If the RNA was fractionated, this could resolve this issue of high 
amounts of reads across the whole genome. Another issue was the high amounts of 16S 
and 23S rRNA sequenced from the pulldowns. The use of whole cell RNA for the 
pulldowns allowed rRNA to bind to RBP, HUβ and HUα.  rRNA depletion should be 
done to alleviate the problem of the rRNA binding non-specifically to the proteins in vitro. 
Also we have moved on to in vivo studies to obtain more biologically relevant data and to 
decrease the binding of 16S and 23S rRNA.  
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The in vivo study will use immunoprecipitation of RBP-RNA complex from P. 
gingivalis. P. gingivalis W83 and mutant protein-RNA complexes will be cross-linked, 
lysed and sonicated to fractionate the RNA.  The RBP-RNA complex will be isolated 
using RBP specific antibody. Western blot will be used to detect the presence of RBP. The 
samples will then be treated with protease and used for RNA sequencing. We can then use 
these sequencing results to help us analyze the reads along the P. gingivalis genome where 
RBP binds. 
We have tested the binding of RBP with RNA from P. gingivalis and shown that 
there is an interaction between the two. From the EMSA reactions using IRE RNA, we see 
that RBP binds to RNA differently than HUβ and HUα. Also, the EMSA reactions using 
the long probe and short probe show that RBP binds specifically to RNA motifs. The in 
vitro studies also indicate that RBP binds with RNA from P. gingivalis, but further studies 
should be done to identify the specific binding sites and the molecular mechanism 
governing the RBP-mediated regulation. 
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